Quaker BioVentures

News

Anti-infective drugmaker Nitric BioTherapeutics grabs $1.7M

Nitric BioTherapeutics Inc., which is developing treatments for athlete’s foot and other infections, has pulled in an additional $1.7 million of an ongoing funding round that’s projected to hit $20 million. The fundraise, which was led by existing investors, brings the company’s total funding to about $16 million since 2006, CEO Frank McCaney said. Nitric […]

By Brandon Glenn

Hospitals

Cleveland Clinic physician named to Regado Biosciences advisory board

Dr. A. Michael Lincoff is part of a new nine-member medical advisory board at Regado Biosciences, a New Jersey company developing a quickly reversible anti-clotting drugs to help with heart problems including acute coronary syndrome.

By Chris Seper

With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?

Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.